BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation
Massachusetts General Hospital
800 participants
Jan 10, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.
Eligibility
Inclusion Criteria5
- Adult caregivers (≥18 years) relative or friend of a patient identified as living with them or having in-person contact with them at least twice a week.
- Caregiver of a patient receiving allogeneic or autologous HCT for the treatment of cancer.
- Ability to read and respond to survey questions in English, Spanish or with minimal assistance from an interpreter.
- Adult patients (≥18 years) with a hematologic malignancy and planned admission for autologous or allogeneic HCT.
- Ability to respond to questions in English, Spanish, or with minimal assistance from an interpreter.
Exclusion Criteria3
- Caregivers of patients undergoing HCT for a benign hematologic condition or undergoing outpatient HCT.
- Caregivers with a major untreated psychiatric or cognitive condition which the treating oncology clinicians believes interferes with the capacity to provide informed consent.
- Caregivers of patients who have already undergone HCT within the past 5 years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Therapist-delivered psychosocial intervention comprised of 6 sessions
Meeting a transplant social worker prior to HCT and as needed for extra visits
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06472089